chr14-56802340-G-A
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_021728.4(OTX2):c.289C>T(p.Arg97*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_021728.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- syndromic microphthalmia type 5Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, Orphanet
- pituitary hormone deficiency, combined, 6Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- combined pituitary hormone deficiencies, genetic formInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- isolated anophthalmia-microphthalmia syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- patterned macular dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- septooptic dysplasiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_021728.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| OTX2 | NM_021728.4 | MANE Select | c.289C>T | p.Arg97* | stop_gained | Exon 5 of 5 | NP_068374.1 | ||
| OTX2 | NM_001270525.2 | c.289C>T | p.Arg97* | stop_gained | Exon 3 of 3 | NP_001257454.1 | |||
| OTX2 | NM_001270523.2 | c.265C>T | p.Arg89* | stop_gained | Exon 5 of 5 | NP_001257452.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| OTX2 | ENST00000672264.2 | MANE Select | c.289C>T | p.Arg97* | stop_gained | Exon 5 of 5 | ENSP00000500115.1 | ||
| OTX2 | ENST00000554845.2 | TSL:1 | c.289C>T | p.Arg97* | stop_gained | Exon 3 of 3 | ENSP00000451357.2 | ||
| OTX2 | ENST00000339475.10 | TSL:1 | c.265C>T | p.Arg89* | stop_gained | Exon 5 of 5 | ENSP00000343819.5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Syndromic microphthalmia type 5 Pathogenic:1
not provided Pathogenic:1
Identified as an inherited change in multiple individuals with anophthalmia and/or microphthalmia or with colobomas, and intrafamilial variability was noted for these cases (Wyatt et al., 2008; Patat et al., 2013; Chassaing et al., 2014); Nonsense variant in the C-terminus predicted to result in protein truncation, as the last 201 amino acids are lost, and other loss-of-function variants have been reported downstream in the Human Gene Mutation Database (HGMD); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 33423259, 18781617, 28388256, 23523800, 24167467, 31969185, 30268123, 31896778, 24033328, 20494911)
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at